Millennium Pharmaceuticals Inc - Product Pipeline Review - 2016

Published: Dec, 2016 | Pages: 61 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Millennium Pharmaceuticals Inc - Product Pipeline Review - 2016

Summary

Global Markets Direct's, 'Millennium Pharmaceuticals Inc - Product Pipeline Review - 2016', provides an overview of the Millennium Pharmaceuticals Inc's pharmaceutical research and development focus. 

The report provides comprehensive information on the therapeutics under development by Millennium Pharmaceuticals Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Millennium Pharmaceuticals Inc
- The report provides overview of Millennium Pharmaceuticals Inc including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Millennium Pharmaceuticals Inc's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Millennium Pharmaceuticals Inc's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons To Buy

- Evaluate Millennium Pharmaceuticals Inc's strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Millennium Pharmaceuticals Inc
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Millennium Pharmaceuticals Inc's pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

 Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Millennium Pharmaceuticals Inc Snapshot 5
Millennium Pharmaceuticals Inc Overview 5
Key Facts 5
Millennium Pharmaceuticals Inc - Research and Development Overview 6
Key Therapeutic Areas 6
Millennium Pharmaceuticals Inc - Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products - Monotherapy 12
Pipeline Products - Out-Licensed Products 13
Out-Licensed Products/Combination Treatment Modalities 14
Millennium Pharmaceuticals Inc - Pipeline Products Glance 15
Millennium Pharmaceuticals Inc - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Phase I Products/Combination Treatment Modalities 16
Millennium Pharmaceuticals Inc - Early Stage Pipeline Products 17
Preclinical Products/Combination Treatment Modalities 17
Discovery Products/Combination Treatment Modalities 18
Millennium Pharmaceuticals Inc - Drug Profiles 19
alisertib - Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
bortezomib - Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
orteronel - Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
pevonedistat hydrochloride - Drug Profile 34
Product Description 34
Mechanism Of Action 34
R&D Progress 34
sapanisertib - Drug Profile 37
Product Description 37
Mechanism Of Action 37
R&D Progress 37
serabelisib - Drug Profile 40
Product Description 40
Mechanism Of Action 40
R&D Progress 40
Small Molecules to Inhibit Histone Deacetylase 6 for Oncology - Drug Profile 42
Product Description 42
Mechanism Of Action 42
R&D Progress 42
TAK-243 - Drug Profile 43
Product Description 43
Mechanism Of Action 43
R&D Progress 43
TAK-580 - Drug Profile 44
Product Description 44
Mechanism Of Action 44
R&D Progress 44
TAK-659 - Drug Profile 46
Product Description 46
Mechanism Of Action 46
R&D Progress 46
TAK-931 - Drug Profile 48
Product Description 48
Mechanism Of Action 48
R&D Progress 48
Millennium Pharmaceuticals Inc - Pipeline Analysis 49
Millennium Pharmaceuticals Inc - Pipeline Products by Target 49
Millennium Pharmaceuticals Inc - Pipeline Products by Route of Administration 51
Millennium Pharmaceuticals Inc - Pipeline Products by Molecule Type 52
Millennium Pharmaceuticals Inc - Pipeline Products by Mechanism of Action 53
Millennium Pharmaceuticals Inc - Dormant Projects 55
Millennium Pharmaceuticals Inc - Discontinued Pipeline Products 56
Discontinued Pipeline Product Profiles 57
alisertib 57
betrixaban 57
bortezomib 57
HuL-2G7 57
indusatumab vedotin 57
IPI-443 58
orteronel 58
TAK-441 58
TAK-733 58
TAK-901 58
TAK-960 58
tandutinib 58
Millennium Pharmaceuticals Inc - Locations And Subsidiaries 59
Head Office 59
Appendix 60
Methodology 60
Coverage 60
Secondary Research 60
Primary Research 60
Expert Panel Validation 60
Contact Us 60
Disclaimer 61

List of Tables

Millennium Pharmaceuticals Inc, Key Facts 5
Millennium Pharmaceuticals Inc - Pipeline by Indication, 2016 7
Millennium Pharmaceuticals Inc - Pipeline by Stage of Development, 2016 11
Millennium Pharmaceuticals Inc - Monotherapy Products in Pipeline, 2016 12
Millennium Pharmaceuticals Inc - Out-Licensed Products in Pipeline, 2016 13
Millennium Pharmaceuticals Inc - Out-Licensed Products/ Combination Treatment Modalities, 2016 14
Millennium Pharmaceuticals Inc - Phase II, 2016 15
Millennium Pharmaceuticals Inc - Phase I, 2016 16
Millennium Pharmaceuticals Inc - Preclinical, 2016 17
Millennium Pharmaceuticals Inc - Discovery, 2016 18
Millennium Pharmaceuticals Inc - Pipeline by Target, 2016 50
Millennium Pharmaceuticals Inc - Pipeline by Route of Administration, 2016 51
Millennium Pharmaceuticals Inc - Pipeline by Molecule Type, 2016 52
Millennium Pharmaceuticals Inc - Pipeline Products by Mechanism of Action, 2016 54
Millennium Pharmaceuticals Inc - Dormant Developmental Projects,2016 55
Millennium Pharmaceuticals Inc - Discontinued Pipeline Products, 2016 56